Terms: = Head and neck cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Treatment
16 results:
1. Hsa_circ_0000345 inhibits cell proliferation, migration and invasion of nasopharyngeal carcinoma cells via miR-513a-3p/PTEN axis.
Jiang C; Li H; Liu F; Shi L; Liu J; Li Y
J Physiol Sci; 2022 May; 72(1):10. PubMed ID: 35545766
[TBL] [Abstract] [Full Text] [Related]
2. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract] [Full Text] [Related]
3. Circular incision and cutting, a novel treatment for patients with esophageal cancer with anastomotic stricture after esophagectomy.
Jie MM; Hu CJ; Tang B; Xie X; Lin H; Yu J; Yang SM
J Dig Dis; 2019 Jan; 20(1):25-30. PubMed ID: 30484968
[TBL] [Abstract] [Full Text] [Related]
4. Sarcoma With cic-DUX4 Gene Fusion: Case Report of Kidney Tumor Location in a 12-year-old Boy.
Camille A; Anne-Sophie B; Cécile P; Severine BC; Gaelle P; Olivier D; Geraldine SS; Leer-Florin AM; Eleni N; Christian P; Chantal D; Dominique P; Hervé S
Pediatr Dev Pathol; 2018; 21(4):406-410. PubMed ID: 28466754
[TBL] [Abstract] [Full Text] [Related]
5. miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer.
Wang X; Guo H; Yao B; Helms J
Oncol Rep; 2017 May; 37(5):2720-2726. PubMed ID: 28350138
[TBL] [Abstract] [Full Text] [Related]
6. Distinct subpopulations of head and neck cancer cells with different levels of intracellular reactive oxygen species exhibit diverse stemness, proliferation, and chemosensitivity.
Chang CW; Chen YS; Chou SH; Han CL; Chen YJ; Yang CC; Huang CY; Lo JF
Cancer Res; 2014 Nov; 74(21):6291-305. PubMed ID: 25217518
[TBL] [Abstract] [Full Text] [Related]
7. Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma.
Piao L; Zhang M; Datta J; Xie X; Su T; Li H; Teknos TN; Pan Q
Mol Ther; 2012 Jun; 20(6):1261-9. PubMed ID: 22491216
[TBL] [Abstract] [Full Text] [Related]
8. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.
Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH
Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of circulating immune complexes and serum immunoglobulins in oral cancer patients--a follow up study.
Parveen S; Taneja N; Bathi RJ; Deka AC
Indian J Dent Res; 2010; 21(1):10-5. PubMed ID: 20427899
[TBL] [Abstract] [Full Text] [Related]
10. Immunological and biochemical markers in oral carcinogenesis: the public health perspective.
Khanna S
Int J Environ Res Public Health; 2008 Dec; 5(5):418-22. PubMed ID: 19151437
[TBL] [Abstract] [Full Text] [Related]
11. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.
Rabassa ME; Croce MV; Pereyra A; Segal-Eiras A
BMC Cancer; 2006 Oct; 6():253. PubMed ID: 17064405
[TBL] [Abstract] [Full Text] [Related]
12. Circulating immune complexes and trace elements (Copper, Iron and Selenium) as markers in oral precancer and cancer : a randomised, controlled clinical trial.
Khanna SS; Karjodkar FR
Head Face Med; 2006 Oct; 2():33. PubMed ID: 17040577
[TBL] [Abstract] [Full Text] [Related]
13. Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck: a study of the hellenic co-operative oncology group (HeCOG).
Makrantonakis P; Pectasides D; Aggouridakis C; Visvikis A; Daniilidis J; Fountzilas G
Am J Clin Oncol; 1999 Dec; 22(6):542-9. PubMed ID: 10597736
[TBL] [Abstract] [Full Text] [Related]
14. [Indicators of immunologic reactivity in children with chronic laryngostenosis].
Tsvetkov EA; Ishchenko LM; Savenko IV; Agadzhanova SN
Vestn Otorinolaringol; 1990; (6):33-6. PubMed ID: 2075675
[TBL] [Abstract] [Full Text] [Related]
15. Circulating immune complexes and chemotherapy response in patients with head and neck cancer.
Blazar BA; Fried MP; Strome M; Clark JR; Sereno P; Rodliff S; Caminear D
Head Neck; 1989; 11(5):431-6. PubMed ID: 2807883
[TBL] [Abstract] [Full Text] [Related]
16. Detection of circulating immune complexes in patients with squamous cell carcinoma of the oral cavity.
Mukhopadhyaya R; Rao RS; Fakih AR; Gangal SG
J Clin Lab Immunol; 1986 Dec; 21(4):189-93. PubMed ID: 3494132
[TBL] [Abstract] [Full Text] [Related]
